Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

BioEnterics Intragastric Balloon: The Italian Experience with 2,515 Patients.

A Genco1, T Bruni, S B Doldi

  • 1Italian Group for Lap-Band, Fondazione IDIS - Città della Scienza, Naples, Italy.

Obesity Surgery
|October 4, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What are the determinants of type of breast surgery following neoadjuvant chemotherapy? An analysis of breast cancer patients among Italian SENONET centers: NEOIMPACT study.

Breast (Edinburgh, Scotland)·2026
Same author

Exploring the prognostic value of resting state brain activity in Disorders of Consciousness: A coordinate-based meta-analysis.

Neuroscience and biobehavioral reviews·2026
Same author

Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

The role of the molecular tumor board: learnings from the ROME trial.

NPJ precision oncology·2026
Same author

Trastuzumab deruxtecan in hormone receptor-positive, HER2-low/-ultralow metastatic breast cancer (DESTINY-Breast06): outcome analyses by time to progression on prior first-line endocrine therapy with CDK4/6 inhibitor and baseline burden of disease.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Chemoradiotherapy for Oesophageal Adenocarcinoma: The Debate is Not Over.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026

The BioEnterics Intragastric Balloon (BIB) is effective for weight loss and improving comorbidities in morbidly obese patients. Previous gastric surgery is a contraindication for BIB placement due to complication risks.

Area of Science:

  • Bariatric Surgery
  • Gastroenterology
  • Obesity Management

Background:

  • The BioEnterics Intragastric Balloon (BIB) is increasingly used for temporary treatment of morbid obesity.
  • Evaluating BIB efficacy in a large patient cohort is crucial for understanding its role in weight management.

Purpose of the Study:

  • To assess the efficacy of the BioEnterics Intragastric Balloon (BIB) for weight loss.
  • To evaluate the impact of BIB on obesity-related co-morbidities.

Main Methods:

  • Retrospective data analysis from the Italian Collaborative Study Group for Lap-Band and BIB (GILB).
  • BIB placement with saline (500-700 ml) and methylene blue (10 ml), followed by diet counseling and medical therapy.
  • Evaluation of mortality, complications, BMI, %EWL, BMI loss, and co-morbidities over 6 months.

Related Experiment Videos

Main Results:

  • 2,515 patients underwent BIB placement; overall complication rate was 2.8%.
  • Significant weight loss observed: mean BMI decreased from 44.4 to 35.4 kg/m², with mean %EWL of 33.9%.
  • Co-morbidities resolved in 44.3% and improved in 44.8% of patients after 6 months.

Conclusions:

  • The BioEnterics Intragastric Balloon (BIB) is an effective bariatric device offering satisfactory weight loss and co-morbidity improvement.
  • Previous gastric surgery represents a contraindication for BIB placement due to increased complication risks.